Status:

COMPLETED

Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure

Lead Sponsor:

Singapore National Eye Centre

Conditions:

Angle Closure Glaucoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a randomised controlled clinical trial to compare laser peripheral iridotomy (LPI) and primary phacoemulsification with intra-ocular lens implantation (phaco/IOL) in the treatment of acute pri...

Detailed Description

AIMS The objective of this study is to conduct a randomised controlled clinical trial to compare LPI and primary phacol/IOL in the treatment of APACG. The specific aim is to compare long-term IOP co...

Eligibility Criteria

Inclusion

  • APACG. In cases where both eyes are eligible, the right eye will be entered.
  • IOP less than or equal to 30 mmHg within 24 hours of presentation and after initiation of medical treatment
  • Significant cataract with best corrected visual acuity equal or less than 6/15
  • Informed consent

Exclusion

  • Secondary causes of angle-closure e.g. subluxed lens, uveitis, trauma and neovascular glaucoma
  • Intumescent cataract (phacomorphic glaucoma)
  • Eyes with anterior chamber depth differing by more than 0.3 mm
  • Eyes with no cataract
  • Active ocular infection in either eye which would prevent surgery
  • Female subjects who are pregnant, nursing or of childbearing potential and not using adequate contraception
  • Participating in another study
  • Previous intraocular eye surgery on the affected eye.
  • Any medical condition which would be a contra-indication to surgery

Key Trial Info

Start Date :

October 1 2001

Trial Type :

INTERVENTIONAL

End Date :

October 1 2007

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT00350428

Start Date

October 1 2001

End Date

October 1 2007

Last Update

October 24 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore National Eye Centre

Singapore, Singapore, 168751